![Roger Meier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roger Meier
Fondatore presso Kinarus AG
Provenienza dei contatti di primo grado di Roger Meier
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Aurealis Oy
![]() Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland.
8
| Holding Company | Biotechnology | 8 |
Kinarus AG
![]() Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
terreActive AG
![]() terreActive AG Information Technology ServicesTechnology Services Part of Die Schweizerische Post AG, terreActive AG is a company that specializes in soar, security orchestration automation and response, ki, ai. The company is based in Aarau, Switzerland. terreActive was acquired by Die Schweizerische Post AG on July 04, 2023. The Swiss company's Security Operations Center is responsible for protecting the IT security infrastructure and preventing cyber attacks. The company was founded in 1996 by Marc-Yves Bächli, Roger Meier. Urs Rufer has been the CEO of the company since 1999.
3
| Subsidiary | Information Technology Services | 3 |
Acthera Therapeutics AG
![]() Acthera Therapeutics AG BiotechnologyHealth Technology Acthera Therapeutics AG is a Swiss biotechnology company that develops synthetic lipid membrane vesicles. The private company is based in Basel, Switzerland. The CEOs are Carlo Bertozzi, Pierre-Alain Monnard. The company was founded by Roger Meier.
3
| Private Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Roger Meier tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
SYNAIRGEN PLC | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree | |
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
University of Maine | College/University | Undergraduate Degree | |
University of St. Gallen | College/University | Masters Business Admin | |
University of Mumbai | College/University | Graduate Degree | |
Organon Pharma (UK) Ltd.
![]() Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of St. Andrews | College/University | Undergraduate Degree | |
Charles River Discovery Research Services Finland Oy
![]() Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Pharmatest Services Oy
![]() Pharmatest Services Oy Miscellaneous Commercial ServicesCommercial Services Pharmatest Services Oy offers translational research services for diseases with unmet clinical needs. It provides full-service research solutions for early drug development. Its focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, the firm develops model and assay development services for its customers. The company was founded by Jussi Halleen and Pirkko Härkönen in 1998 and is headquartered in Turku, Finland. | Miscellaneous Commercial Services | Director/Board Member | |
University of Basel | College/University | Doctorate Degree Graduate Degree | |
University of Zurich | College/University | Doctorate Degree | |
International Institute for Management Development | College/University | Masters Business Admin | |
SPEXIS AG | Pharmaceuticals: Major | Director/Board Member | |
Cilag AG
![]() Cilag AG Miscellaneous Commercial ServicesCommercial Services Cilag AG conducts pharmaceutical research and development activities. It is an international operating company integrated in the pharmaceuticals group of Johnson & Johnson that provides its customers with APIs, health care and pharmaceutical products worldwide. The company was founded in 1936 by Dr. Bernhard Joos and is headquartered in Schaffhausen, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vertex Pharmaceuticals (Europe) Ltd.
![]() Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom. | Medical Distributors | Chief Executive Officer | |
Biogen SA | Sales & Marketing | ||
Osuuskunta KPY
![]() Osuuskunta KPY Financial ConglomeratesFinance Osuuskunta KPY operates as a long-term investor. It also rents office space and invests in securities. The company was founded in 1883 and is headquartered in Kuopio, Finland. | Financial Conglomerates | Director/Board Member | |
Ulrich Jüstrich Holding AG
![]() Ulrich Jüstrich Holding AG Investment ManagersFinance Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company. | Investment Managers | Director/Board Member | |
Novaremed AG
![]() Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Pharmaceuticals: Major | Chief Executive Officer | |
Gorba AG
![]() Gorba AG Electronics DistributorsDistribution Services Gorba AG supplies complete passenger information systems for public transportation. It provides exterior displays, interior displays, control units, on board computers, countdown displays, matrix and Thin Film Transistor displays, as well as central software for destination and stationary systems, and software for operations management. The firm also offers accessories like passenger counters and exterior cameras. The company was founded on 1982 and is headquartered in Oberbüren, Switzerland. | Electronics Distributors | Corporate Officer/Principal | |
Helvecura Cooperative Society | Director/Board Member | ||
Hänseler AG
![]() Hänseler AG Pharmaceuticals: MajorHealth Technology Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Krebsforschung Schweiz | Director/Board Member | ||
Hänseler Holding AG | Chairman | ||
Sirius Healthcare Partners GmbH
![]() Sirius Healthcare Partners GmbH Investment ManagersFinance Sirius Healthcare Partners GmbH provides independent advice to small and mid-cap healthcare companies, venture capital firms, institutional and private investors. The firm's services include strategic advisory, mergers and acquisition and financing advisory. It serves in the area of biotechnology, medical technology and diagnostics, platform technologies and healthcare markets. The company was founded by Subhasis Roy, Khalid Islam, Ernesto Mancosu, Werner Tschollar, Andreas Vogler and Mikael von Euw and is headquartered in Zurich, Switzerland. | Investment Managers | Founder | |
Nexilis AG
![]() Nexilis AG BiotechnologyHealth Technology Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron. | Biotechnology | Director/Board Member | |
Allecra Therapeutics GmbH
![]() Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Swiss Cancer Foundation | Director/Board Member | ||
The Fuqua School of Business | College/University | Masters Business Admin | |
University of Eastern Finland | College/University | Doctorate Degree | |
Nostetta Oy
![]() Nostetta Oy Investment ManagersFinance Nostetta Oy (Nostetta) is a venture capital firm founded in 2013. The firm is headquartered in Kuopio, Finland. | Investment Managers | Director/Board Member | |
Cellestia Biotech AG
![]() Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Mavena International AG
![]() Mavena International AG Pharmaceuticals: MajorHealth Technology Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Strekin AG
![]() Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company is based in Basel, Switzerland and was founded in 2014. | Biotechnology | Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
Hthc High Tech Home Care AG | Chairman | ||
Just Finance AG | Director/Board Member | ||
Vital Solutions Swiss AG | Chairman | ||
NLS PHARMACEUTICS AG | Pharmaceuticals: Major | Director of Finance/CFO | |
InterAx Biotech AG
![]() InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Synendos Therapeutics AG
![]() Synendos Therapeutics AG Medical SpecialtiesHealth Technology Synendos Therapeutics AG develops molecules for the treatment of anxiety and stress-related disorders. The company was founded by Andrea Chicca, Simon Russell and Jürg Gertsch in April 2019 and is headquartered in Allschwil, Switzerland. | Medical Specialties | Director/Board Member | |
Aurealis Pharma AG
![]() Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
Helvecura Genossenschaft | Director/Board Member | ||
Artidis AG
![]() Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Vaccentis AG | Director/Board Member | ||
Celloryx AG | Director/Board Member |
Statistiche
Distribuzione geografica
Svizzera | 34 |
Finlandia | 6 |
Stati Uniti | 5 |
Regno Unito | 5 |
Germania | 3 |
Settori
Health Technology | 18 |
Consumer Services | 11 |
Commercial Services | 6 |
Finance | 5 |
Distribution Services | 3 |
Posizioni
Director/Board Member | 52 |
Chief Executive Officer | 16 |
Corporate Officer/Principal | 13 |
Chief Tech/Sci/R&D Officer | 7 |
Chairman | 6 |
Contatti più connessi
- Borsa valori
- Insiders
- Roger Meier
- Connessioni Società